Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 3/2010

01-09-2010 | Erratum

Erratum to: Survey of familial glioma and role of germline p16 INK4A /p14 ARF and p53 mutation

Authors: Lindsay B. Robertson, Georgina N. Armstrong, Bianca D. Olver, Amy L. Lloyd, Sanjay Shete, Ching Lau, Elizabeth B. Claus, Jill Barnholtz-Sloan, Rose Lai, Dora Il’yasova, Joellen Schildkraut, Jonine L. Bernstein, Sara H. Olson, Robert B. Jenkins, Ping Yang, Amanda Lynn Rynearson, Margaret Wrensch, Lucie McCoy, John K. Wienkce, Bridget McCarthy, Faith Davis, Nicholas A. Vick, Christoffer Johansen, Hanne Bødtcher, Siegal Sadetzki, Revital Bar-Sade Bruchim, Galit Hirsh Yechezkel, Ulrika Andersson, Beatrice S. Melin, Melissa L. Bondy, Richard S. Houlston

Published in: Familial Cancer | Issue 3/2010

Login to get access

Excerpt

Unfortunately, one of the co-author’s name has been misspelled in the original article as “Amanda L. Rynerason”. The correct name is Amanda Lynn Rynearson. …
Metadata
Title
Erratum to: Survey of familial glioma and role of germline p16 INK4A /p14 ARF and p53 mutation
Authors
Lindsay B. Robertson
Georgina N. Armstrong
Bianca D. Olver
Amy L. Lloyd
Sanjay Shete
Ching Lau
Elizabeth B. Claus
Jill Barnholtz-Sloan
Rose Lai
Dora Il’yasova
Joellen Schildkraut
Jonine L. Bernstein
Sara H. Olson
Robert B. Jenkins
Ping Yang
Amanda Lynn Rynearson
Margaret Wrensch
Lucie McCoy
John K. Wienkce
Bridget McCarthy
Faith Davis
Nicholas A. Vick
Christoffer Johansen
Hanne Bødtcher
Siegal Sadetzki
Revital Bar-Sade Bruchim
Galit Hirsh Yechezkel
Ulrika Andersson
Beatrice S. Melin
Melissa L. Bondy
Richard S. Houlston
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2010
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-010-9353-6

Other articles of this Issue 3/2010

Familial Cancer 3/2010 Go to the issue

OriginalPaper

Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma

BriefCommunication

Juvenile nasopharyngeal angiofibroma: no evidence for inheritance or association with familial adenomatous polyposis

OriginalPaper

Surgical prophylaxis in familial adenomatous polyposis: do pre-existing desmoids outside the abdominal cavity matter?

OriginalPaper

Atypical identification of Lynch syndrome by immunohistochemistry and microsatellite instability analysis on jejunal adenocarcinoma

OriginalPaper

Screening for germline DND1 mutations in testicular cancer patients

Letter

LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits